Ceramide-induced apoptosis in renal tubular cells: A role of mitochondria and sphingosine-1-phoshate

International Journal of Molecular Sciences

Volumn 16, Issue 3, 2015, Pages 5076-5124

  Ueda, Norishi ^a  

^a Public Central Hospital of Matto Ishikawa   (Japan)

Author keywords

Bcl 2 family proteins; Caspases; Ceramide; Growth factors; Mitochondria; Mitogen activated protein kinases; Reactive oxygen species; Renal tubular cells; Sphingosine 1 phosphate

Indexed keywords

CASPASE; CERAMIDE; CYTOCHROME C; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SPHINGOSINE 1 PHOSPHATE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

APOPTOSIS; AUTOPHAGY; BIOSYNTHESIS; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; HOMEOSTASIS AND REGULATION; HUMAN; HUMAN CELL; HYDROLYSIS KINETICS; KIDNEY TUBULE CELL; METABOLIC REGULATION; MITOCHONDRIAL DYNAMICS; REVIEW; SIGNAL TRANSDUCTION; STRESS; ANALOGS AND DERIVATIVES; ANIMAL; CYTOLOGY; DRUG EFFECTS; KIDNEY TUBULE; METABOLISM; MITOCHONDRION;

ANIMALS; APOPTOSIS; CELL MEMBRANE PERMEABILITY; CERAMIDES; HUMANS; KIDNEY TUBULES; LYSOPHOSPHOLIPIDS; MITOCHONDRIA; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84925845944     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16035076     Document Type: Review

References (226)

1. Hait, N.C.; Oskeritzian, C.A.; Paugh, S.W.; Milstien, S.; Spiegel, S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 2006, 1758, 2016–2026.
2. Bartke, N.; Hannun, Y.A. Bioactive sphingolipids: Metabolism and function. J. Lipid Res. 2009, 50, S91–S96.
3. Hannun, Y.A.; Obeid, L.M. Many ceramides. J. Biol. Chem. 2011, 286, 27855–27862.
4. Siskind, L.J. Mitochondrial ceramide and the induction of apoptosis. J. Bioenerg. Biomembr. 2005, 37, 143–153.
5. Colombini, M. Ceramide channels and their role in mitochondria-mediated apoptosis. Biochim. Biophys. Acta 2010, 1797, 1239–1244.
6. Yu, J.; Novgorodov, S.A.; Chudakova, D.; Zhu, H.; Bielawska, A.; Bielawski, J.; Obeid, L.M.; Kindy, M.S.; Gudz, T.I. JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction. J. Biol. Chem. 2007, 282, 25940–25949.
7. Gault, C.R.; Eblen, S.T.; Neumann, C.A.; Hannun, Y.A.; Obeid, L.M. Oncogenic K-Ras regulates bioactive sphingolipids in a sphingosine kinase 1-dependent manner. J. Biol. Chem. 2012, 287, 31794–31803.
8. Sheng, G.; Guo, J.; Warner, B.W. Epidermal growth factor receptor signaling modulates apoptosis via p38α MAPK-dependent activation of Bax in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293, G599–G606.
9. Qiu, L.; Zhou, C.; Sun, Y.; Di, W.; Scheffler, E.; Healey, S.; Wanebo, H.; Kouttab, N.; Chu, W.; Wan, Y. Paclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cells. Oncol. Rep. 2006, 16, 907–913.
10. Kitatani, K.; Idkowiak-Baldys, J.; Hannun, Y. The sphingolipid salvage pathway in ceramide metabolism and signalling. Cell. Signal. 2008, 20, 1010–1018.
11. Mullen, T.D.; Jenkins, R.W.; Clarke, C.J.; Bielawski, J.; Hannun, Y.A.; Obeid, L.M. Ceramide synthase-dependent ceramide generation and programmed cell death: Involvement of salvage pathway in regulating postmitochondrial events. J. Biol. Chem. 2011, 286, 15929–15942.
12. Ishibashi, Y.; Kohyama-Koganeya, A.; Hirabayashi, Y. New insights on glucosylated lipids: Metabolism and functions. Biochim. Biophys. Acta 2013, 1831, 1475–1485.
13. Novgorodov, S.A.; Chudakova, D.A.; Wheeler, B.W.; Bielawski, J.; Kindy, M.S.; Obeid, L.M.; Gudz, T.I. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis. J. Biol. Chem. 2011, 286, 4644–4658.
14. Mesicek, J.; Lee, H.; Feldman, T.; Jiang, X.; Skobeleva, A.; Berdyshev, E.V.; Haimovitz-Friedman, A.; Fuks, Z.; Kolesnick, R. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell. Signal. 2010, 22, 1300–1307.
15. Wu, B.X.; Rajagopalan, V.; Roddy, P.L.; Clarke, C.J.; Hannun, Y.A. Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5. J. Biol. Chem. 2010, 285, 17993–18002.
16. Novgorodov, S.A.; Wu, B.X.; Gudz, T.I.; Bielawski, J.; Ovchinnikova, T.V.; Hannun, Y.A.; Obeid, L.M. Novel pathway of ceramide production in mitochondria: Thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA. J. Biol. Chem. 2011, 286, 25352–25362.
17. Subathra, M.; Qureshi, A.; Luberto, C. Sphingomyelin synthases regulate protein trafficking and secretion. PLos One 2011, 6, e23644.
18. Ledeen, R.W.; Wu, G. Nuclear sphingolipids: Metabolism and signalling. J. Lipid Res. 2008, 49, 1176–1186.
19. Kumagai, K.; Kawano-Kawada M, Hanada, K. Phosphoregulation of the ceramide transport protein CERT at serine 315 in the interaction with VAMP-associated protein (VAP) for inter-organelle trafficking of ceramide in mammalian cells. J. Biol. Chem. 2014, 289, 10748–10760.
20. Giussani, P.; Maceyka, M.; le Stunff, H.; Mikami, A.; Lépine, S.; Wang, E.; Kelly, S.; Merrill, A.H., Jr.; Milstien, S.; Spiegel, S. Sphingosine-1-phosphate phosphohydrolase regulates endoplasmic reticulum-to-Golgi trafficking of ceramide. Mol. Cell. Biol. 2006, 26, 5055–5069.
21. Stiban, J.; Caput, L.; Colombini M. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 2008, 49, 625–634.
22. Babiychuk, E.B.; Atanassoff, A.P.; Monastyrskaya, K.; Brandenberger, C.; Studer, D.; Allemann, C.; Draeger, A. The targeting of plasmalemmal ceramide to mitochondria during apoptosis. PLoS One 2011, 6, e23706.
23. Tomassini, B.; Testi, R. Mitochondria as sensors of sphingolipids. Biochimie 2002, 84, 123–129.
24. Li, X.; Gulbins, E.; Zhang, Y. Oxidative stress triggers Ca2+-dependent lysosome trafficking and activation of acid sphingomyelinase. Cell. Physiol. Biochem. 2012, 30, 815–826.
25. Wang, G.; Krishnamurthy, K.; Bieberich, E. Regulation of primary cilia formation by ceramide. J. Lipid Res. 2009, 50, 2103–2110.
26. He, Q.; Wang, G.; Dasgupta, S.; Dinkins, M.; Zhu, G.; Bieberich, E. Characterization of an apical ceramide-enriched compartment regulating ciliogenesis. Mol. Biol. Cell 2012, 23, 3156–3166.
27. Bakrac, B.; Kladnik, A.; Macek, P.; McHaffie, G.; Werner, A.; Lakey, J.H.; Anderluh, G. A toxin-based probe reveals cytoplasmic exposure of Golgi sphingomyelin. J. Biol. Chem. 2010, 285, 22186–22195.
28. Ueda, Y.; Makino, A.; Murase-Tamada, K.; Sakai, S.; Inaba, T.; Hullin-Matsuda, F.; Kobayashi, T. Sphingomyelin regulates the transbilayer movement of diacylglycerol in the plasma membrane of Madin–Darby canine kidney cells. FASEB J. 2013, 27, 3284–3297.
29. Kok, J.W.; Eskelinen, S.; Hoekstra, K.; Hoekstra, D. Salvage of glucosylceramide by recycling after internalization along the pathway of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 1989, 86, 9896–9900.
30. Ebel, P.; Vom Dorp, K.; Petrasch-Parwez, E.; Zlomuzica, A.; Kinugawa, K.; Mariani, J.; Minich, D.; Ginkel, C.; Welcker, J.; Degen, J, et al. Inactivation of ceramide synthase 6 in mice results in an altered sphingolipid metabolism and behavioral abnormalities. J. Biol. Chem. 2013, 288, 21433–21447.
31. Basnakian, A.G.; Ueda, N.; Hong, X.; Galitovsky, V.E.; Yin, X.; Shah, S.V. Ceramide synthase is essential for endonuclease-mediated death of renal tubular epithelial cells induced by hypoxia-reoxygenation. Am. J. Physiol. Ren. Physiol. 2005, 288, F308–F314.
32. Ueda, N.; Kaushal, G.P.; Hong, X.; Shah, S.V. Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Kidney Int. 1998, 54, 399–406.
33. Ueda, N.; Camargo, S.M.; Hong, X.; Basnakian, A.G.; Walker, P.D.; Shah, S.V. Role of ceramide synthase in oxidant injury to renal tubular epithelial cells. J. Am. Soc. Nephrol. 2001, 12, 2384–2391.
34. Pewzner-Jung, Y.; Brenner, O.; Braun, S.; Laviad, E.L.; Ben-Dor, S.; Feldmesser, E.; Horn-Saban, S.; Amann-Zalcenstein, D.; Raanan, C.; Berkutzki, T, et al. A critical role for ceramide synthase 2 in liver homeostasis: II. Insights into molecular changes leading to hepatopathy. J. Biol. Chem. 2010, 285, 10911–10923.
35. Mitsutake, S.; Tani, M.; Okino, N.; Mori, K.; Ichinose, S.; Omori, A.; Iida, H.; Nakamura, T.; Ito, M. Purification, characterization, molecular cloning, and subcellular distribution of neutral ceramidase of rat kidney. J. Biol. Chem. 2001, 276, 26249–26259.
36. Sacket, S.J.; Chung, H.Y.; Okajima, F.; Im, D.S. Increase in sphingolipid catabolic enzyme activity during aging. Acta Pharmacol. Sin. 2009, 30, 1454–1461.
37. Park, S.W.; Kim, M.; Kim, J.Y.; Brown, K.M.; Haase, V.H.; D’Agati, V.D.; Lee, H.T. Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. Kidney Int. 2012, 82, 878–891.
38. Siskind, L.J.; Mullen, T.D.; Romero Rosales, K.; Clarke, C.J.; Hernandez-Corbacho, M.J.; Edinger, A.L.; Obeid, L.M. The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis. J. Biol. Chem. 2010, 285, 11818–11826.
39. Sridevi, P.; Alexander, H.; Laviad, E.L.; Min, J.; Mesika, A.; Hannink, M.; Futerman, A.H.; Alexander, S. Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp. Cell. Res. 2010, 316, 78–91.
40. Tomiuk, S.; Zumbansen, M.; Stoffel, W. Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J. Biol. Chem. 2000, 275, 5710–5717.
41. Ghosh, P.; Chatterjee, S. Effects of gentamicin on sphingomyelinase activity in cultured human renal proximal tubular cells. J. Biol. Chem. 1987, 262, 12550–12556.
42. Koch, A.; Pfeilschifter, J.; Huwiler, A. Sphingosine 1-phosphate in renal diseases. Cell. Physiol. Biochem. 2013, 31, 745–760.
43. Hofmann, L.P.; Ren, S.; Schwalm, S.; Pfeilschifter, J.; Huwiler, A. Sphingosine kinase 1 and 2 regulate the capacity of mesangial cells to resist apoptotic stimuli in an opposing manner. Biol. Chem. 2008, 389, 1399–1407.
44. Kim, M.; Kim, M.; Kim, N.; D’Agati, V.D.; Emala, C.W., Sr.; Lee, H.T. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1- phosphate-dependent pathways. Am. J. Physiol. Ren. Physiol. 2007, 293, F1827–F1835.
45. Park, S.W.; Kim, J.Y.; Ham, A.; Brown, K.M.; Kim, M.; D’Agati, V.D.; Lee, H.T. A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injury. Am. J. Physiol. Ren. Physiol. 2012, 303, F721–F732.
46. Ter Braak, M.; Danneberg, K.; Lichte, K.; Liphardt, K.; Ktistakis, N.T.; Pitson, S.M.; Hla, T.; Jakobs, K.H.; Meyerzu Heringdorf, D. Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors. Biochim. Biophys. Acta 2009, 1791, 357–370.
47. Maceyka, M.; Sankala, H.; Hait, N.C.; le Stunff, H.; Liu, H.; Toman, R.; Collier, C.; Zhang, M.; Satin, L.S.; Merrill, A.H., Jr, et al. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 2005, 280, 37118–37129.
48. Kurokawa, M.; Kornbluth, S. Caspases and kinases in a death grip. Cell 2009, 138, 838–854.
49. Chipuk, J.E.; Moldoveanu, T.; Llambi, F.; Parsons, M.J.; Green, D.R. The BCL-2 family reunion. Mol. Cell 2010, 37, 299–310.
50. Tsao, C.C.; Nica, A.F.; Kurinna, S.M.; Jiffar, T.; Mumby, M.; Ruvolo, P.P. Mitochondrial protein phosphatase 2A regulates cell death induced by simulated ischemia in kidney NRK-52E cells. Cell Cycle 2007, 6, 2377–2385.
51. Zager, R.A.; Iwata, M.; Conrad, D.S.; Burkhart, K.M.; Igarashi, Y. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int. 1997, 52, 60–70.
52. Zager, R.A.; Conrad, S.; Lochhead, K.; Sweeney, E.A.; Igarashi, Y.; Burkhart, K.M. Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure. Kidney Int. 1998, 53, 573–582.
53. Zager, R.A.; Conrad, D.S.; Burkhart, K. Ceramide accumulation during oxidant renal tubular injury: Mechanisms and potential consequences. J. Am. Soc. Nephrol. 1998, 9, 1670–1680.
54. Cao, L.C.; Honeyman, T.; Jonassen, J.; Scheid, C. Oxalate-induced ceramide accumulation in Madin–Darby canine kidney and LLC-PK1 cells. Kidney Int. 2000, 57, 2403–2411.
55. Chatterjee, M.; Wu, S. Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis. Mol. Cell. Biochem. 2001, 219, 21–27.
56. Niimura, Y.; Moue, T.; Takahashi, N.; Nagai, K. Modification of sphingoglycolipids and sulfolipids in kidney cell lines under heat stress: Activation of monohexosylceramide synthesis as a ceramide scavenger. Glycobiology 2010, 20, 710–717.
57. Cao, L.C.; Honeyman, T.W.; Cooney, R.; Kennington, L.; Scheid, C.R.; Jonassen, J.A. Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int. 2004, 66, 1890–1900.
58. Fischer, H.; Ellström, P, Ekström, K.; Gustafsson, L.; Gustafsson, M.; Svanborg, C. Ceramide as a TLR4 agonist; A putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR 4. Cell. Microbiol. 2007, 9, 1239–1251.
59. Hedlund, M.; Duan, R.D.; Nilsson, A.; Svanborg, C. Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P-fimbriated Escherichia coli. Mol. Microbiol. 1998, 29, 1297–1306.
60. Lee, W.K.; Torchalski, B.; Thévenod, F. Cadmium-induced ceramide formation triggers calpain-dependent apoptosis in cultured kidney proximal tubule cells. Am. J. Physiol. Cell Physiol. 2007, 293, C839–C847.
61. Lee, W.K.; Thévenod, F. Novel roles for ceramides, calpains and caspases in kidney proximal tubule cell apoptosis: Lessons from in vitro cadmium toxicity studies. Biochem. Pharmacol. 2008, 76, 1323–1332.
62. Lochhead, K.M.; Zager, R.A. Fluorinated anesthetic exposure “activates” the renal cortical sphingomyelinase cascade. Kidney Int. 1998, 54, 373–381.
63. Li, T.; Ying, L.; Wang, H.; Li, N.; Fu, W.; Guo, Z.; Xu, L. Microcystin-LR induces ceramide to regulate PP2A and destabilize cytoskeleton in HEK293 cells. Toxicol. Sci. 2012, 128, 147–157.
64. Dahdouh, F.; Raane, M.; Thévenod, F.; Lee, W.K. Nickel-induced cell death and survival pathways in cultured renal proximal tubule cells: Roles of reactive oxygen species, ceramide and ABCB 1. Arch. Toxicol. 2014, 88, 881–892.
65. Itoh, Y.; Yano, T.; Sendo, T.; Sueyasu, M.; Hirano, K.; Kanaide, H.; Oishi, R. Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int. 2006, 69, 288–297.
66. Chatterjee, S.; Neill, R.; Shupp, J.W.; Hammamieh, R.; Ionin, B.; Jett, M. Identification of staphylococcal enterotoxin B domains involved in binding to cultured human kidney proximal tubular cells: Imparting proliferation and death. Exp. Biol. Med. (Maywood) 2007, 232, 1142–1151.
67. Ichi, I.; Kamikawa, C.; Nakagawa, T.; Kobayashi, K.; Kataoka, R.; Nagata, E.; Kitamura, Y.; Nakazaki, C.; Matsura, T.; Kojo, S. Neutral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon tetrachloride intoxication. Toxicology 2009, 261, 33–40.
68. Malik, R.K.; Thornhill, B.A.; Chang, A.Y.; Kiley, S.C.; Chevalier, R.L Apoptosis parallels ceramide content in the developing rat kidney. Pediatr. Nephrol. 2000, 15, 188–191.
69. Facchinetti, M.M.; Beuret, C.; Marquez, M.G.; Sterin-Speziale, N. Differential branching of the sphingolipid metabolic pathways with the stage of development. Involvement of sphingosine kinase. Biol. Neonate 2003, 84, 243–251.
70. Malik, R.K.; Thornhill, B.A.; Chang, A.Y.; Kiley, S.C.; Chevalier, R.L. Renal apoptosis parallels ceramide content after prolonged ureteral obstruction in the neonatal rat. Am. J. Physiol. Ren. Physiol. 2001, 281, F56–F61.
71. Iwayama, H.; Ueda, N. Role of mitochondrial Bax, caspases, and MAPKs for ceramide-induced apoptosis in renal proximal tubular cells. Mol. Cell. Biochem. 2013, 379, 37–42.
72. Burlaka, I.; Liu, X.L.; Rebetz, J.; Arvidsson, I.; Yang, L.; Brismar, H.; Karpman, D.; Aperia, A. Ouabain protects against Shiga toxin-triggered apoptosis by reversing the imbalance between Bax and Bcl-xL. J. Am. Soc. Nephrol. 2013, 24, 1413–1423.
73. Idkowiak-Baldys, J.; Apraiz, A.; Li, L.; Rahmaniyan, M.; Clarke, C.J.; Kraveka, J.M.; Asumendi, A.; Hannun, Y.A. Dihydroceramide desaturase activity is modulated by oxidative stress. Biochem. J. 2010, 427, 265–274.
74. Ghosh Choudhury, G.; Zhang, J.H.; Ghosh-Choudhury, N.; Abboud, H.E. Ceramide blocks PDGF-induced DNA synthesis in mesangial cells via inhibition of Akt kinase in the absence of apoptosis. Biochem. Biophys. Res. Commun. 2001, 286, 1183–1190.
75. Iwata, M.; Herrington, J.; Zager R.A. Sphingosine: A mediator of acute renal tubular injury and subsequent cytoresistance. Proc. Natl. Acad. Sci. USA 1995, 92, 8970–8974.
76. Sharma, N.; He, Q.; Sharma, R.P. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells. Chem. Biol. Interact. 2004, 151, 33–42.
77. Seefelder, W.; Humpf, H.U.; Schwerdt, G.; Freudinger, R.; Gekle, M. Induction of apoptosis in cultured human proximal tubule cells by fumonisins and fumonisin metabolites. Toxicol. Appl. Pharmacol. 2003, 192, 146–153.
78. He Q, Riley R.T.; Sharma, R.P. Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): A model for reducing fumonisin-induced nephrotoxicity in vivo. Pharmacol. Toxicol. 2002, 90, 268–277.
79. Jo, S.K.; Bajwa, A.; Awad, A.S.; Lynch, K.R.; Okusa, M.D. Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney Int. 2008, 73, 1220–1230.
80. Kim, M.; Kim, M.; Park, S.W.; Pitson, S.M.; Lee, H.T. Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. Am. J. Nephrol. 2010, 31, 353–362.
81. Bajwa, A.; Jo, S.K.; Ye, H.; Huang, L.; Dondeti, K.R.; Rosin, D.L.; Haase, V.H.; Macdonald, T.L.; Lynch, K.R.; Okusa, M.D. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J. Am. Soc. Nephrol. 2010, 21, 955–965.
82. Park, S.W.; Kim, M.; Brown, K.M.; D’Agati, V.D.; Lee, H.T. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 2012, 23, 266–280.
83. Ishizawa, S.; Takahashi-Fujigasaki, J.; Kanazawa, Y.; Matoba, K.; Kawanami, D.; Yokota, T.; Iwamoto, T.; Tajima, N.; Manome, Y.; Utsunomiya, K. Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. Clin. Exp. Nephrol. 2014, 18, 844–852.
84. Park, S.W.; Kim, M.; Kim, M.; D'Agati, V.D.; Lee, H.T. Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int. 2011, 80, 1315–1327.
85. Bakar, A.M.; Park, S.W.; Kim, M.; Lee, H.T. Isoflurane protects against human endothelial cell apoptosis by inducing sphingosine kinase-1 via ERK MAPK. Int. J. Mol. Sci. 2012, 13, 977–993.
86. Kim, M.; Park, S.W.; Kim, M.; D’Agati, V.D.; Lee, H.T. Isoflurane activates intestinal sphingosine kinase to protect against renal ischemia-reperfusion-induced liver and intestine injury. Anesthesiology 2011, 114, 363–373.
87. Lee, H.T.; Park, S.W.; Kim, M.; Ham, A.; Anderson, L.J.; Brown, K.M.; D’Agati, V.D.; Cox G.N. Interleukin-11 protects against renal ischemia and reperfusion injury. Am. J. Physiol. Ren. Physiol. 2012, 303, F1216–F1224.
88. Nieto, F.L.; Pescio, L.G.; Favale, N.O.; Adamo, A.M.; Sterin-Speziale, N.B. Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin–Darby canine kidney (MDCK) cells. J. Biol. Chem. 2008, 283, 25682–25691.
89. Johnson, K.R.; Johnson, K.Y.; Becker, K.P.; Bielawski, J.; Mao, C.; Obeid, L.M. Role of human sphingosine-1-phosphate phosphatase 1 in the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell viability. J. Biol. Chem. 2003, 278, 34541–34547.
90. Mandala, S.M.; Thornton, R.; Galve-Roperh, I.; Poulton, S.; Peterson, C.; Olivera, A.; Bergstrom, J.; Kurtz, M.B.; Spiegel, S. Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1-phosphate and induces cell death. Proc. Natl. Acad. Sci. USA 2000, 97, 7859–7864.
91. Oskouian, B.; Sooriyakumaran, P.; Borowsky, A.D.; Crans, A.; Dillard-Telm, L.; Tam, Y.Y.; Bandhuvula, P.; Saba, J.D. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc. Natl. Acad. Sci. USA 2006, 103, 17384–17389.
92. Kirby, R.J.; Jin, Y.; Fu, J.; Cubillos, J.; Swertfeger, D.; Arend, L.J. Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney. Am. J. Physiol. Ren. Physiol. 2009, 296, F634–F641.
93. Chandran, S.; Machamer, C.E. Inactivation of ceramide transfer protein during pro-apoptotic stress by Golgi disassembly and caspase cleavage. Biochem. J. 2012, 442, 391–401.
94. Milhas, D.; Clarke, C.J.; Idkowiak-Baldys, J.; Canals, D.; Hannun, Y.A. Anterograde and retrograde transport of neutral sphingomyelinase-2 between the Golgi and the plasma membrane. Biochim. Biophys. Acta 2010, 1801, 1361–1374.
95. Jin, S.; Yi, F.; Zhang, F.; Poklis, J.L.; Li, P.L. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28, 2056–2062.
96. Ruggiero, C.; Elks, C.M.; Kruger, C.; Cleland, E.; Addison, K.; Noland, R.C.; Stadler, K. Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis. Am. J. Physiol. Ren. Physiol. 2014, 306, F896–F906.
97. Aschrafi, A.; Franzen, R.; Shabahang, S.; Fabbro, D.; Pfeilschifter, J.; Huwiler, A. Ceramide induces translocation of protein kinase C-α to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domain. Biochim. Biophys. Acta 2003, 1634, 30–39.
98. Serlachius, E.; Svennilson, J.; Schalling, M.; Aperia, A. Protein kinase C in the developing kidney: Isoform expression and effects of ceramide and PKC inhibitors. Kidney Int. 1997, 52, 901–910.
99. Wang, S.; Dong, Z. Primary cilia and kidney injury: Current research status and future perspectives. Am. J. Physiol. Ren. Physiol. 2013, 305, F1085–F1098.
100. Nicotera, P.; Melino, G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23, 2757–2765.
101. Wu, C.C.; Bratton, S.B. Regulation of the intrinsic apoptosis pathway by reactive oxygen species. Antioxid. Redox Signal. 2013, 19, 546–558.
102. Quillet-Mary, A.; Jaffrézou, J.P.; Mansat, V.; Bordier, C.; Naval, J.; Laurent, G. Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J. Biol. Chem. 1997, 272, 21388–21395.
103. Sawada, M.; Nakashima, S.; Banno, Y.; Yamakawa, H.; Takenaka, K.; Shinoda, J.; Nishimura, Y.; Sakai, N.; Nozawa, Y. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 2000, 19, 3508–3520.
104. Leber, B.; Lin, J.; Andrews, D.W. Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis 2007, 12, 897–911.
105. Pavlov, E.V.; Priault, M.; Pietkiewicz, D.; Cheng, E.H.; Antonsson, B.; Manon, S.; Korsmeyer, S.J.; Mannella, C.A.; Kinnally, K.W. A novel, high conductance channel of mitochondria linked to apoptosis in mammalian cells and Bax expression in yeast. J. Cell Biol. 2001, 155, 725–731.
106. Dejean, L.M.; Martinez-Caballero, S.; Guo, L.; Hughes, C.; Teijido, O.; Ducret, T.; Ichas, F.; Korsmeyer, S.J.; Antonsson, B.; Jonas, E.A.; Kinnally, K.W. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol. Biol. Cell. 2005, 16, 2424–2432.
107. Dejean, L.M.; Martinez-Caballero, S.; Kinnally, K.W. Is MAC the knife that cuts cytochrome C from mitochondria during apoptosis? Cell Death Differ. 2006, 13, 1387–1395.
108. Chipuk, J.E.; McStay, G.P.; Bharti, A.; Kuwana, T.; Clarke, C.J.; Siskind, L.J.; Obeid, L.M.; Green, D.R. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 2012, 148, 988–1000.
109. Kashkar, H.; Wiegmann, K.; Yazdanpanah, B.; Haubert, D.; Krönke, M. Acid sphingomyelinase is indispensable for UV light-induced Bax conformational change at the mitochondrial membrane. J. Biol. Chem. 2005, 280, 20804–20813.
110. Lee, H.; Rotolo, J.A.; Mesicek, J.; Penate-Medina, T.; Rimner, A.; Liao, W.C.; Yin, X.; Ragupathi, G.; Ehleiter, D.; Gulbins, E, et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS One 2011, 6, e19783.
111. Sawai, H.; Kawai, S.; Domae, N. Reduced expression of Bax in ceramide-resistant HL-60 subline. Biochem. Biophys. Res. Commun. 2004, 319, 46–49.
112. Ganesan, V.; Perera, M.N.; Colombini, D.; Datskovskiy, D.; Chadha, K.; Colombini M. Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis 2010, 15, 553–562.
113. Siskind, L.J.; Colombini, M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 2000, 275, 38640–38644.
114. Siskind L.J.; Feinstein L.; Yu T.; Davis J.S.; Jones D.; Choi J.; Zuckerman J.E.; Tan W.; Hill R.B.; Hardwick J.M, et al. Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels. J. Biol. Chem. 2008, 283, 6622–6630.
115. Perera, M.N.; Lin, S.H.; Peterson, Y.K.; Bielawska, A.; Szulc, Z.M.; Bittman, R.; Colombini, M. Bax and Bcl-xL exert their regulation on different sites of the ceramide channel. Biochem. J. 2012, 445, 81–91.
116. Elrick, M.J.; Fluss, S.; Colombini, M. Sphingosine, a product of ceramide hydrolysis, influences the formation of ceramide channels. Biophys. J. 2006, 91, 1749–1756.
117. Stiban, J.; Fistere, D.; Colombini, M. Dihydroceramide hinders ceramide channel formation: Implications on apoptosis. Apoptosis 2006, 11, 773–780.
118. Baines, C.P.; Kaiser, R.A.; Sheiko, T.; Craigen, W.J.; Molkentin, J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell. Biol. 2007, 9, 550–555.
119. Rapizzi, E.; Pinton, P.; Szabadkai, G.; Wieckowski, M.R.; Vandecasteele, G.; Baird, G.; Tuft, R.A.; Fogarty, K.E.; Rizzuto, R. Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J. Cell Biol. 2002, 159, 613–624.
120. Scharstuhl, A.; Mutsaers, H.A.; Pennings, S.W.; Russel, F.G.; Wagener, F.A. Involvement of VDAC, Bax and ceramides in the efflux of AIF from mitochondria during curcumin-induced apoptosis. PLoS One 2009, 4, e6688.
121. Schwarz, M.; Andrade-Navarro, M.A.; Gross, A. Mitochondrial carriers and pores: Key regulators of the mitochondrial apoptotic program? Apoptosis 2007, 12, 869–876.
122. Martínez-Abundis, E.; Correa, F.; Pavón N.; Zazueta, C. Bax distribution into mitochondrial detergent-resistant microdomains is related to ceramide and cholesterol content in postischemic hearts. FEBS J. 2009, 276, 5579–5588.
123. Roy S.S.; Madesh, M.; Davies, E.; Antonsson, B.; Danial, N.; Hajnóczky, G. Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol. Cell 2009, 33, 377–388.
124. Novgorodov, S.A.; Szulc, Z.M.; Luberto, C.; Jones, J.A.; Bielawski, J.; Bielawska, A.; Hannun, Y.A.; Obeid, L.M. Positively charged ceramide is a potent inducer of mitochondrial permeabilization. J. Biol. Chem. 2005, 280, 16096–16105.
125. Darios, F.; Lambeng, N.; Troadec, J.D.; Michel, P.P.; Ruberg, M. Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: Role in initiation of cell death. J. Neurochem. 2003, 84, 643–654.
126. Pinton, P.; Ferrari, D.; Rapizzi, E.; Di Virgilio, F.; Pozzan, T.; Rizzuto, R. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: Significance for the molecular mechanism of Bcl-2 action. EMBO J. 2001, 20, 2690–2701.
127. Parra, V.; Eisner, V.; Chiong, M.; Criollo, A.; Moraga, F.; Garcia, A.; Härtel, S.; Jaimovich, E.; Zorzano, A.; Hidalgo, C.; et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis. Cardiovasc. Res. 2008, 77, 387–397.
128. Arnoult, D.; Rismanchi, N.; Grodet, A.; Roberts, R.G.; Seeburg, D.P.; Estaquier, J.; Sheng, M.; Blackstone, C. Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated mitochondrial fission and mitoptosis during programmed cell death. Curr. Biol. 2005, 15, 2112–2118.
129. Brooks, C.; Wei, Q.; Feng, L.; Dong, G.; Tao, Y.; Mei, L.; Xie, Z.J.; Dong, Z. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proc. Natl. Acad. Sci. USA 2007, 104, 11649–11654.
130. Sheridan, C.; Delivani, P.; Cullen, S.P.; Martin, S.J. Bax- or Bak-induced mitochondrial fission can be uncoupled from cytochrome C release. Mol. Cell 2008, 31, 570–585.
131. Miller, C.; Kennington, L.; Cooney, R.; Kohjimoto, Y.; Cao, L.C.; Honeyman, T.; Pullman, J.; Jonassen, J.; Scheid, C. Oxalate toxicity in renal epithelial cells: Characteristics of apoptosis and necrosis. Toxicol. Appl. Pharmacol. 2000, 162, 132–141.
132. Dagher, P.C. Apoptosis in ischemic renal injury: Roles of GTP depletion and p53 Kidney Int. 2004, 66, 506–509.
133. Cabral, L.M.; Wengert, M.; da Ressurreição, A.A.; Feres-Elias, P.H.; Almeida, F.G.; Vieyra, A.; Caruso-Neves, C.; Einicker-Lamas, M. Ceramide is a potent activator of plasma membrane Ca2+-ATPase from kidney-promixal tubule cells with protein kinase A as an intermediate. J. Biol. Chem. 2007, 282, 24599–24606.
134. Cho, S.G.; Du, Q.; Huang, S.; Dong, Z. Drp1 dephosphorylation in ATP depletion-induced mitochondrial injury and tubular cell apoptosis. Am. J. Physiol. Ren. Physiol. 2010, 299, F199–F206.
135. Saito, M.; Korsmeyer, S.J.; Schlesinger, P.H. BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell. Biol. 2000, 2, 553–555.
136. Antonsson, B.; Montessuit, S.; Lauper, S.; Eskes, R.; Martinou, J.C. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem. J. 2000, 345, 271–278.
137. Roucou, X.; Rostovtseva, T.; Montessuit, S.; Martinou, J.C.; Antonsson, B. Bid induces cytochrome c-impermeable Bax channels in liposomes. Biochem. J. 2002, 363, 547–552.
138. Listenberger, L.L.; Ory, D.S.; Schaffer, J.E. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 2001, 276, 14890–14895.
139. Suzuki, J.; Akahane, K.; Nakamura, J.; Naruse, K.; Kamiya, H.; Himeno, T.; Nakamura, N.; Shibata, T.; Kondo, M.; Nagasaki, H., et al. Palmitate induces apoptosis in Schwann cells via both ceramide-dependent and independent pathways. Neuroscience 2011, 176, 188–198.
140. Srivastava, S.; Chan, C. Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: Relation to mitochondrial permeability transition. Free Radic. Res. 2007, 41, 38–49.
141. Beverly, L.J.; Howell, L.A.; Hernandez-Corbacho, M.; Casson, L.; Chipuk, J.E.; Siskind, L.J. BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins. Biochem. J. 2013, 452, 111–119.
142. Ravid, T.; Tsaba, A.; Gee, P.; Rasooly, R.; Medina, E.A.; Goldkorn, T. Ceramide accumulation precedes caspase-3 activation during apoptosis of A549 human lung adenocarcinoma cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284, L1082–L1092.
143. Bektas, M.; Jolly, P.S.; Müller, C.; Eberle, J.; Spiegel, S.; Geilen, C.C. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: Role of Bcl-2 expression. Oncogene 2005, 24, 178–187.
144. Zigdon, H.; Kogot-Levin, A.; Park, J.W.; Goldschmidt, R.; Kelly, S.; Merrill A H Jr., Scherz, A.; Pewzner-Jung, Y.; Saada, A.; Futerman, A.H. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain. J. Biol. Chem. 2013, 288, 4947–4956.
145. Phillips, D.C.; Allen, K.; Griffiths, H.R. Synthetic ceramides induce growth arrest or apoptosis by altering cellular redox status. Arch. Biochem. Biophys. 2002, 407, 15–24.
146. Pautz, A.; Franzen, R.; Dorsch, S.; Böddinghaus, B.; Briner, V.A.; Pfeilschifter, J.; Huwiler, A. Cross-talk between nitric oxide and superoxide determines ceramide formation and apoptosis in glomerular cells. Kidney Int. 2002, 61, 790–796.
147. Huwiler, A.; Pfeilschifter, J.; van den Bosch, H. Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J. Biol. Chem. 1999, 274, 7190–7195.
148. Grammatikos, G.; Teichgräber, V.; Carpinteiro, A.; Trarbach, T.; Weller, M.; Hengge, U.R.; Gulbins, E. Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. Antioxid. Redox Signal. 2007, 9, 1449–1456.
149. Cinq-Frais, C.; Coatrieux, C.; Grazide, M.H.; Hannun, Y.A.; Nègre-Salvayre, A.;Salvayre, R.; Augé, N. A signaling cascade mediated by ceramide, Src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase- 1. Biochim. Biophys. Acta 2013, 1831, 1344–1356.
150. Levy, M.; Castillo, S.S.; Goldkorn, T. NSMase2 activation and trafficking are modulated by oxidative stress to induce apoptosis. Biochem. Biophys. Res. Commun. 2006, 344, 900–905.
151. Maceyka, M.; Milstien, S.; Spiegel, S. Shooting the messenger: Oxidative stress regulates sphingosine-1-phosphate. Circ. Res. 2007, 100, 7–9.
152. Pyszko, J.; Strosznajder, J.B. Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells. Mol. Neurobiol. 2014, 50, 38–48.
153. Kizhakkayil, J.; Thayyullathil, F.; Chathoth, S.; Hago, A.; Patel, M.; Galadari, S. Glutathione regulates caspase-dependent ceramide production and curcumin-induced apoptosis in human leukemic cells. Free Radic. Biol. Med. 2012, 52, 1854–1864.
154. Levy, M.; Khan, E.; Careaga, M.; Goldkorn, T. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297, L125–L133.
155. Charruyer, A.; Jean, C.; Colomba, A.; Jaffrézou, J.P.; Quillet-Mary, A.; Laurent, G.; Bezombes, C. PKCprotects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production. Biochem. J. 2007, 405, 77–83.
156. Bruce, C.R.; Risis, S.; Babb, J.R.; Yang, C.; Kowalski, G.M.; Selathurai, A.; Lee-Young, R.S.; Weir, J.M.; Yoshioka, K.; Takuwa, Y., et al. Overexpression of sphingosine kinase 1 prevents ceramide accumulation and ameliorates muscle insulin resistance in high-fat diet-fed mice. Diabetes 2012, 61, 3148–3155.
157. Franzen, R.; Pfeilschifter, J.; Huwiler, A. Nitric oxide induces neutral ceramidase degradation by the ubiquitin/proteasome complex in renal mesangial cell cultures. FEBS Lett. 2002, 532, 441–444.
158. Lan, T.; Liu, W.; Xie, X.; Xu, S.; Huang, K.; Peng, J.; Shen, X.; Liu, P.; Wang, L.; Xia, P.; Huang, H. Sphingosine kinase-1 pathway mediates high glucose-induced fibronectin expression in glomerular mesangial cells. Mol. Endocrinol. 2011, 25, 2094–2105.
159. Esposti, M.D.; Hatzinisiriou, I.; McLennan, H.; Ralph, S. Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes. J. Biol. Chem. 1999, 274, 29831–29837.
160. Krishna, S.; Low, I.C.; Pervaiz, S. Regulation of mitochondrial metabolism: Yet another facet in the biology of the oncoprotein Bcl- 2. Biochem. J. 2011, 435, 545–551.
161. Amarante-Mendes, G.P.; Naekyung Kim, C.; Liu, L.; Huang, Y.; Perkins, C.L.; Green, D.R.; Bhalla, K. Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase- 3. Blood 1998, 91, 1700–1705.
162. Kirkland, R.A.; Saavedra, G.M.; Cummings, B.S.; Franklin, J.L. Bax regulates production of superoxide in both apoptotic and nonapoptotic neurons: Role of caspases. J. Neurosci. 2010, 30, 16114–16127.
163. D’Errico, I.; lo Sasso, G.; Salvatore, L.; Murzilli, S.; Martelli, N.; Cristofaro, M.; Latorre, D.; Villani, G.; Moschetta, A. Bax is necessary for PGC1α pro-apoptotic effect in colorectal cancer cells. Cell Cycle 2011, 10, 2937–2945.
164. Henke, N.; Lisak, D.A.; Schneider, L.; Habicht, J.; Pergande, M.; Methne, A. The ancient cell death suppressor BAX inhibitor- 1. Cell Calcium 2011, 50, 251–260.
165. Nie, C.; Tian, C.; Zhao, L.; Petit, P.X.; Mehrpour, M.; Chen, Q. Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis. J. Biol. Chem. 2008, 283, 15359–15369.
166. Yang, D.; Yang, D.; Jia, R.; Ding, G. Selective inhibition of the reverse mode of Na+/Ca2+ exchanger attenuates contrast-induced cell injury. Am. J. Nephrol. 2013, 37, 264–273.
167. Oh, H.L.; Seok, J.Y.; Kwon, C.H.; Kang, S.K.; Kim, Y.K. Role of MAPK in ceramide-induced cell death in primary cultured astrocytes from mouse embryonic brain. Neurotoxicology 2006, 27, 31–38.
168. Flowers, M.; Fabriás, G.; Delgado, A.; Casas, J.; Abad, J.L.; Cabot, M.C. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth. Breast Cancer Res. Treat. 2012, 133, 447–458.
169. Thévenod, F.; Lee, W.K. Cadmium and cellular signaling cascades: Interactions between cell death and survival pathways. Arch. Toxicol. 2013, 87, 1743–1786.
170. Morales, M.C.; Pérez-Yarza, G.; Rementería, N.N.; Boyano, M.D.; Apraiz, A.; Gómez-Muñoz, A.; Pérez-Andrés, E.; Asumendi, A. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl- 2. Free Radic. Res. 2007, 41, 591–601.
171. Kobrinsky, E.; Spielman, A.I.; Rosenzweig, S.; Marks, A.R. Ceramide triggers intracellular calcium release via the IP(3) receptor in Xenopus laevis oocytes. Am. J. Physiol. Cell Physiol. 1999, 277, C665–C672.
172. Heath-Engel, H.M.; Chang, N.C.; Shore, G.C. The endoplasmic reticulum in apoptosis and autophagy: Role of the BCL-2 protein family. Oncogene 2008, 27, 6419–6433.
173. Senkal, C.E.; Ponnusamy, S.; Manevich, Y.; Meyers-Needham, M.; Saddoughi, S.A.; Mukhopadyay, A.; Dent, P.; Bielawski, J.; Ogretmen, B. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network. J. Biol. Chem. 2011, 286, 42446–42458.
174. Szabadkai, G.; Bianchi, K.; Várnai, P.; de Stefani, D.; Wieckowski, M.R.; Cavagna, D.; Nagy, A.I.; Balla, T.; Rizzuto, R. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol. 2006, 175, 901–911.
175. Darios, F.; Muriel, M.P.; Khondiker, M.E.; Brice, A.; Ruberg, M. Neurotoxic calcium transfer from endoplasmic reticulum to mitochondria is regulated by cyclin-dependent kinase 5-dependent phosphorylation of tau. J. Neurosci. 2005, 25, 4159–4168.
176. Yacoub, A.; Hamed, H.A.; Allegood, J.; Mitchell, C.; Spiegel, S.; Lesniak, M.S.; Ogretmen, B.; Dash, R.; Sarkar, D.; Broaddus, W.C, et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res. 2010, 70, 1120–1129.
177. Scorrano, L.; Oakes, S.A.; Opferman, J.T.; Cheng, E.H.; Sorcinelli, M.D.; Pozzan, T.; Korsmeyer, S.J. BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis. Science 2003, 300, 135–139.
178. Logue, S.E.; Cleary, P.; Saveljeva, S.; Samali, A. New directions in ER stress-induced cell death. Apoptosis 2013, 18, 537–546.
179. Fiebig, A.A.; Zhu, W.; Hollerbach, C.; Leber, B.; Andrews, D.W. Bcl-XL is qualitatively different from and ten times more effective than Bcl-2 when expressed in a breast cancer cell line. BMC Cancer 2006, 6, 213.
180. Hsin, Y.H.; Cheng, C.H.; Tzen, J.T.; Wu, M.J.; Shu, K.H.; Chen H C. Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells. Apoptosis 2006, 11, 2167–2177.
181. Dremina, E.S.; Sharov, V.S.; Kumar, K.; Zaidi, A.; Michaelis, E.K.; Schöneich, C. Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). Biochem. J. 2004, 383, 361–370.
182. Monaco, G.; Beckers, M.; Ivanova, H.; Missiaen, L.; Parys, J.B.; de Smedt, H.; Bultynck, G. Profiling of the Bcl-2/Bcl-XL-binding sites on type 1 IP3 receptor. Biochem. Biophys. Res. Commun. 2012, 428, 31–35.
183. Camandola, S.; Cutler, R.G.; Gary, D.S.; Milhavet, O.; Mattson, M.P. Suppression of calcium release from inositol 1,4,5-trisphosphate-sensitive stores mediates the anti-apoptotic function of nuclear factor-κB. J. Biol. Chem. 2005, 280, 22287–22296.
184. Xu, C.; Xu, W.; Palmer, A.E.; Reed, J.C. BI-1 regulates endoplasmic reticulum Ca2+ homeostasis downstream of Bcl-2 family proteins. J. Biol. Chem. 2008, 283, 11477–11484.
185. Willaime, S.; Vanhoutte, P.; Caboche, J.; Lemaigre-Dubreuil, Y.; Mariani, J.; Brugg, B. Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur. J. Neurosci. 2001, 13, 2037–2046.
186. Stoica, B.A.; Movsesyan, V.A.; Knoblach, S.M.; Faden, A.I. Ceramide induces neuronal apoptosis through mitogen-activated protein kinases and causes release of multiple mitochondrial proteins. Mol. Cell. Neurosci. 2005, 29, 355–371.
187. Falluel-Morel, A.; Aubert, N.; Vaudry, D.; Basille, M.; Fontaine, M.; Fournier, A.; Vaudry, H.; Gonzalez, B.J. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 2004, 91, 1231–1243.
188. Sun, Y.; Fox, T.; Adhikary, G.; Kester, M.; Pearlman, E. Inhibition of corneal inflammation by liposomal delivery of short-chain, C-6 ceramide. J. Leukoc. Biol. 2008, 83, 1512–1521.
189. Willaime-Morawek, S.; Brami-Cherrier, K.; Mariani, J.; Caboche, J.; Brugg, B. c-Jun N-terminal kinases/c-Jun and p38 pathways cooperate in ceramide-induced neuronal apoptosis. Neuroscience 2003, 119, 387–397.
190. Donato, N.J.; Klostergaard, J. Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Exp. Cell Res. 2004, 294, 523–533.
191. Zhuang, S.; Yan, Y.; Daubert, R.A.; Han, J.; Schnellmann, R.G. ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am. J. Physiol. Ren. Physiol. 2007, 292, F440–F447.
192. Bourbon, N.A.; Yun, J.; Berkey, D.; Wang, Y.; Kester, M. Inhibitory actions of ceramide upon PKC-ε/ERK interactions. Am. J. Physiol. Cell Physiol. 2001, 280, C1403–C1411.
193. Sathyanarayana, P.; Barthwal, M.K.; Kundu, C.N.; Lane, M.E.; Bergmann, A.; Tzivion, G.; Rana, A. Activation of the Drosophila MLK by ceramide reveals TNF-α and ceramide as agonists of mammalian MLK 3. Mol. Cell 2002, 10, 1527–1533.
194. Huwiler, A.; Xin, C.; Brust, A.K.; Briner, V.A.; Pfeilschifter, J. Differential binding of ceramide to MEKK1 in glomerular endothelial and mesangial cells. Biochim. Biophys. Acta 2004, 1636, 159–168.
195. Chen, C.L.; Lin, C.F.; Chang, W.T.; Huang, W.C.; Teng, C.F.; Lin, Y.S. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 2008, 111, 4365–4374.
196. Park, M.A.; Walker, T.; Martin, A.P.; Allegood, J.; Vozhilla, N.; Emdad, L.; Sarkar, D.; Rahmani, M.; Graf, M.; Yacoub, A, et al. MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanism. Mol. Cancer Ther. 2009, 8, 1280–1291.
197. Pfeilschifter, J.; Huwiler, A. Identification of ceramide targets in interleukin-1 and tumor necrosis factor-α signaling in mesangial cells. Kidney Int. Suppl. 1998, 67, S34–S39.
198. Bourbon, N.A.; Yun, J.; Kester, M. Ceramide directly activates protein kinase Cζ to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 2000, 275, 35617–35623.
199. Yabu, T.; Shiba, H.; Shibasaki, Y.; Nakanishi, T.; Imamura, S.; Touhata, K.; Yamashita, M. Stress-induced ceramide generation and apoptosis via the phosphorylation and activation of nSMase1 by JNK signalling. Cell Death Differ. 2015, 22, 258–273.
200. Bizzozero, L.; Cazzato, D.; Cervia, D.; Assi, E.; Simbari, F.; Pagni, F.; de Palma, C.; Monno, A.; Verdelli, C.; Querini, P.R., et al. Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway. Cell Death Differ. 2014, 21, 507–520.
201. Sridevi, P.; Alexander, H.; Laviad, E.L.; Pewzner-Jung, Y.; Hannink, M.; Futerman, A.H.; Alexander, S. Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochim. Biophys. Acta 2009, 1793, 1218–1227.
202. Franzen, R.; Pautz, A.; Bräutigam, L.; Geisslinger, G.; Pfeilschifter, J.; Huwiler, A. Interleukin-1β induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J. Biol. Chem. 2001, 276, 35382–35389.
203. Kim, H.J.; Oh, J.E.; Kim, S.W.; Chun, Y.J.; Kim, M.Y. Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. Cancer Lett. 2008, 260, 88–95.
204. Herrmann, J.L.; Menter, D.G.; Beham, A.; von Eschenbach, A.; McDonnell, T.J. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp. Cell Res. 1997, 234, 442–451.
205. Manna, S.K.; Haridas, V.; Aggarwal, B.B. Bcl-xL suppresses TNF-mediated apoptosis and activation of nuclear factor-kB, activation protein-1, and c-Jun N-terminal kinase. J. Interferon Cytokine Res. 2000, 20, 725–735.
206. Wang, M.; Crager, M.; Pugazhenthi, S. Modulation of apoptosis pathways by oxidative stress and autophagy in β cells. Exp. Diabetes Res. 2012, 2012, 647914.
207. Kurinna, S.M.; Tsao, C.C.; Nica, A.F.; Jiffar, T.; Ruvolo, P.P. Ceramide promotes apoptosis in lung cancer-derived A549 cells by a mechanism involving c-Jun NH2-terminal kinase. Cancer Res. 2004, 64, 7852–7856.
208. Asakuma, J.; Sumitomo, M.; Asano, T.; Asano, T.; Hayakawa, M. Selective Akt inactivation and tumor necrosis factor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res. 2003, 63, 1365–1370.
209. Gao, P.; Peterson, Y.K.; Smith, R.A.; Smith, C.D. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. PLoS One 2012, 7, e44543.
210. Rutherford, C.; Childs, S.; Ohotski, J.; McGlynn, L.; Riddick, M.; MacFarlane, S.; Tasker, D.; Pyne, S.; Pyne, N.J.; Edwards, J.; et al. Regulation of cell survival by sphingosine-1-phosphate receptor S1P1 via reciprocal ERK-dependent suppression of Bim and PI-3-kinase/protein kinase C-mediated upregulation of Mcl- 1. Cell Death Dis. 2013, 4, e927.
211. Betito, S.; Cuvillier, O. Regulation by sphingosine 1-phosphate of Bax and Bad activities during apoptosis in a MEK-dependent manner. Biochem. Biophys. Res. Commun. 2006, 340, 1273–1277.
212. El-Shewy, H.M.; Sohn, M.; Wilson, P.; Lee, M.H.; Hammad, S.M.; Luttrell, L.M.; Jaffa, A.A. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol. Endocrinol. 2012, 26, 833–845.
213. Pitson, S.M.; Moretti, P.A.; Zebol, J.R.; Lynn, H.E.; Xia, P.; Vadas, M.A.; Wattenberg, B.W. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003, 22, 5491–5500.
214. Gibson, S.B. Epidermal growth factor and trail interactions in epithelial-derived cells. Vitam. Horm. 2004, 67, 207–227.
215. Mimeault, M.; Pommery, N.; Hénichart, J.P. Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase A inhibitors in human prostatic cancer cell lines. Int. J. Cancer 2003, 106, 116–124.
216. Auge, N.; Garcia, V.; Maupas-Schwalm, F.; Levade, T.; Salvayre, R.; Negre-Salvayre, A. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler. Thromb. Vasc. Biol. 2002, 22, 1990–1995.
217. Zhao, S.; Du, X.Y.; Chen, J.S.; Zhou, Y.C.; Song, J.G. Secretory phospholipase A2 inhibits epidermal growth factor-induced receptor activation. Exp. Cell Res. 2002, 279, 354–364.
218. Reinehr, R.; Becker, S.; Eberle, A.; Grether-Beck, S.; Häussinger, D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 2005, 280, 27179–27194.
219. Johnstone, E.D.; Mackova, M.; Das, S.; Payne, S.G.; Lowen, B.; Sibley, C.P.; Chan, G.; Guilbert, L.J. Multiple anti-apoptotic pathways stimulated by EGF in cytotrophoblasts. Placenta 2005, 26, 548–555.
220. Sarkar, S.; Maceyka, M.; Hait, N.C.; Paugh, S.W.;Sankala, H.; Milstien, S.; Spiegel, S. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 2005, 579, 5313–5317.
221. Yogi, A.; Callera, G.E.; Aranha, A.B.; Antunes, T.T.; Graham, D.; McBride, M.; Dominiczak, A.; Touyz, R.M. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: Upregulation in hypertension. Hypertension 2011, 57, 809–818.
222. Meyer zu Heringdorf, D.; Lass, H.; Kuchar, I.; Alemany, R.; Guo, Y.; Schmidt, M.; Jakobs, K.H. Role of sphingosine kinase in Ca2+ signalling by epidermal growth factor receptor. FEBS Lett. 1999, 461, 217–222.
223. Iwayama, H.; Sakamoto, T.; Nawa, A.; Ueda, N. Crosstalk between Smad and mitogen-activated protein kinases for the regulation of apoptosis in cyclosporine A-induced renal tubular injury. Nephron Extra 2011, 1, 178–189.
224. El-Shewy, H.M.; Abdel-Samie, S.A.; al Qalam, A.M.; Lee, M.H.; Kitatani, K.; Anelli, V.; Jaffa, A.A.; Obeid, L.M.; Luttrell, L.M. Phospholipase C and protein kinase C-β 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation. Mol. Endocrinol. 2011, 25, 2144–2156.
225. Fatatis, A.; Miller, R.J. Cell cycle control of PDGF-induced Ca2+ signaling through modulation of sphingolipid metabolism. FASEB J. 1999, 13, 1291–1301.
226. Olivera, A.; Edsall, L.; Poulton, S.; Kazlauskas, A.; Spiegel, S. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCγ. FASEB J. 1999, 13, 1593–1600.